Macular Edema and Macular Degeneration Growth Trajectory: Key Forecasts and Strategic Insights
Discover trends, market shifts, and competitive outlooks for the macular edema and macular degeneration industry through 2025-2034 with The Business Research Company’s reliable data and in-depth research
What is the Anticipated CAGR of the Macular Edema and Macular Degeneration Market, and What Factors Will Drive It?
The market for macular edema and macular degeneration has experienced healthy expansion recently. It is projected to increase in size from $9.65 billion in 2024 to $10.43 billion in 2025, representing a compound annual growth rate (CAGR) of 8.1%. Factors that have contributed to this growth historically include an older demographic, higher cases of diabetes, increased awareness and early detection, international efforts towards eye health, advances in pharmaceuticals, and the role of patient advocacy and support.
The market size for macular edema and macular degeneration is forecasted to experience significant growth in the upcoming years. By 2029, it’s projected to reach $13.71 billion, with a compound annual growth rate (CAGR) of 7.1%. This anticipated growth within the forecast period is due to various factors such as the implementation of personalized medicine strategies, increased awareness in developing markets, emphasis on combined therapies, and the incorporation of teleophthalmology services amidst a globally aging population. Future trends expected to shape the market during this period encompass advancements in prolonged-release drug distribution, the inclusion of gene therapies, the progression of innovative imaging techniques, individualized treatment methods utilizing biomarkers, the use of teleophthalmology for distance monitoring, and improvements in artificial intelligence for diagnostic purposes.
Download a free sample to assess the report’s scope and structure:
https://www.thebusinessresearchcompany.com/sample.aspx?id=13479&type=smp
Which Factors and External Forces Are Driving Demand in the Macular Edema and Macular Degeneration Market?
The expansion of the macular edema and macular degeneration market is anticipated due to the escalating number of diabetes patients. High blood sugar levels characterize diabetes, a chronic health disorder which harms the eye’s blood vessels, leading to macular edema and macular degeneration. As stated by The National Health Service (NHS England), a UK-based state-funded healthcare system, in 2024, there was an 18% increase in pre-diabetes cases identified by NHS in England, rising from 3,065,825 in 2022 to 3,615,330 in 2023. Notably, in individuals younger than 40, there was almost a 25% rise in cases from 173,166 in 2022 to 216,440 in 2023. Thus, the growing diabetes population is fueling the progression of the macular edema and macular degeneration market.
Macular Edema and Macular Degeneration Market Driver: Rising Occurrences of Eye Conditions Boosts Macular Edema and Macular Degeneration Market
Which Segments in the Macular Edema and Macular Degeneration Offer the Most Growth?
The macular edema and macular degeneration market covered in this report is segmented –
1) By Treatment Type: Drug Therapy, Laser Treatment
2) By Application: Macular Edema, Diabetic Macular Edema (DME), Cystoid Macular Edema (CME), Macular Degeneration, Dry age-related macular degeneration, Wet age-related macular degeneration
3) By End User: Hospitals, Clinics, Other End Users
Subsegments:
1) By Drug Therapy: Anti-VEGF (Vascular Endothelial Growth Factor) Injections, Steroid Injections, Oral Medications, Combination Therapy (Anti-VEGF + Steroids)
2) By Laser Treatment: Focal Laser Photocoagulation, Panretinal Photocoagulation (PRP), Subthreshold Laser Therapy, MicroPulse Laser Therapy
Request customized data on this market:
https://www.thebusinessresearchcompany.com/customise?id=13479&type=smp
What Are the Fastest-Growing Geographies in the Macular Edema and Macular Degeneration Market?
North America was the largest region in the macular edema and macular degeneration market in 2024. The regions covered in the macular edema and macular degeneration market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Which Cutting-Edge Market Trends Are Expected to Drive theMacular Edema and Macular Degeneration Market’s Growth?
Key businesses in the macular edema and macular degeneration market are channeling their efforts towards designing new products like Vabysmo (faricimab-svoa) to enhance their market profitability. Vabysmo is a medicinal product used in the treatment of neovascular age-related macular degeneration (nAMD) and diabetic macular edema (DME). A notable example of this is Genentech Inc., a biotech company from the US, which received FDA approval for Vabysmo in January 2022. This medicine is the first of its kind bispecific monoclonal antibody, targeting vascular endothelial growth factor (VEGF) and angiopoietin 2 (Ang-2). With the potential to emerge as a popular solution for nAMD and DME, the approval of faricimab by the FDA and EU marks a significant milestone for Genentech and Roche.
View the full report here:
What Are the Key Elements That Define the Macular Edema and Macular Degeneration Market?
Macular edema and macular degeneration are two different eye conditions that can affect vision. Macular edema is swelling in the part of the retina at the back of the eye, which can cause blurry vision. Macular degeneration is a condition that affects the macula, a part of the retina at the back of the eye that is responsible for central vision. They can be caused by many different conditions, including diabetic retinopathy, retinal vein occlusion, and inflammation, and include age, genetics, smoking, high blood pressure, and obesity.
Purchase the full report and get a swift delivery:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=13479
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
